Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability-Reference-Cited by-同舟云学术

Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability

Published:2009-05-01 Issue:22 Volume:48 Page:4816-4827
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Lieberman Raquel L.¹²,D’aquino J. Alejandro²,Ringe Dagmar²,Petsko Gregory A.¹²

Affiliation:

1. Structural Neurology Lab at the Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115

2. Rosenstiel Basic Biomedical Sciences Research Center, Brandeis University, 415 South Street, Waltham, Massachusetts 02454

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi9002265

Reference80 articles.

1. A view of acidic intracellular compartments.

2. The cell biology of lysosomal storage disorders

3. Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease

4. Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression.

5. Analyses of Variant Acid β-Glucosidases

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terra incognita of glial cell dynamics in the etiology of leukodystrophies: Broadening disease and therapeutic perspectives;Life Sciences;2024-10

2. Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease;Bioorganic Chemistry;2024-05

3. Mechanistic Insights into Dibasic Iminosugars as pH-Selective Pharmacological Chaperones to Stabilize Human α-Galactosidase;JACS Au;2024-02-23

4. Structural and dynamics insights into the GBA variants associated with Parkinson’s disease;Journal of Biomolecular Structure and Dynamics;2023-07-11

5. Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues;Pharmacology & Therapeutics;2023-06